Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD

por Kupčová, Viera, Fedelešová, Michaela, Bulas, Jozef, Kozmonová, Petra, Turecký, Ladislav
Publicado 2019

Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment

por Jensen, Lene, Kupcova, Viera, Arold, Gerhard, Pettersson, Jonas, Hjerpsted, Julie B.
Publicado 2018

Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment

por Kupčová, Viera, Arold, Gerhard, Roepstorff, Carsten, Højbjerre, Malene, Klim, Søren, Haahr, Hanne
Publicado 2013

Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment

por Bækdal, Tine A., Thomsen, Mette, Kupčová, Viera, Hansen, Cilie W., Anderson, Thomas W.
Publicado 2018

The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954)

por Czerniak, Richard, Cieslarová, Blanka, Kupčová, Viera, Rosario, Maria, Lock, Ruth, Dong, Cheng, Dukes, George
Publicado 2022